Publications by authors named "Yaquine Mechelfekh"
Article Synopsis
- Obinutuzumab (GA101) is a monoclonal antibody used for treating B-cell cancers, but it can rarely cause severe thrombocytopenia, known as obinutuzumab-induced acute thrombocytopenia (OIAT).
- This report details two cases of OIAT: a 74-year-old woman with follicular lymphoma and a 44-year-old woman with mantle cell lymphoma, both experiencing significant drops in platelet counts after treatment.
- The article emphasizes the importance of awareness among healthcare providers regarding OIAT to improve detection and management of this serious condition.
